Aurora cannabis announces fiscal 2025 third quarter results

Nasdaq | tsx: acb reports total net revenue1 of $88.2 million, up 37% yoy, including record net revenue1 of $68.1 million in global medical cannabis, up 51% yoy generates record net income of $31.2 million, up 282% yoy, and record adjusted ebitda1 of $23.1 million, up 316% yoy achieves target of positive free cash flow1 in q3, generating $27.4 million of free cash flow1 maintains strong balance sheet with $180 million of cash and debt-free cannabis business2 edmonton, ab , feb. 5, 2025 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: acb) (tsx: acb), a leading canada-based global medical cannabis company, today announced its financial and operational results for the third quarter fiscal 2025. "this quarter was record-breaking for aurora, driven by all-time highs in global medical net revenue1, net income, adjusted ebitda1, and free cash flow1.
ACB Ratings Summary
ACB Quant Ranking